Maze Therapeutics MAZE
NASDAQ MAZE
$32.35 -0.10 (-0.31%)
As of: Oct 21, 2026 · 11:41 AM EDT

Maze Therapeutics (MAZE) EPS (Diluted) (2024 - 2026)

Updated

Maze Therapeutics' EPS (Diluted) was -$0.76 in Q2 2026, compared with -$0.77 a year earlier.

Analysis

Maze Therapeutics (MAZE) EPS (Diluted) (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Maze Therapeutics' EPS (Diluted) was -$2.26 through Jun 30, 2026; for FY2025, it came in at -$3.05.

  • In earlier years, EPS (Diluted) was $1.25 in FY2024.
  • Quarterly EPS (Diluted) has moved between -$13.91 (Q1 2024) and $3.22 (Q2 2024) over five years.
  • Per Business Quant data, MAZE's EPS (Diluted) in the three quarters before Q2 2026 was -$0.45 (Q1 2026), -$0.80 (Q4 2025) and -$0.66 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 7.94
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 2.27
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 2.04
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn -0.54
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 1.67
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 1.60
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 4.37
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -8.44
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn -0.04
10 Maze Therapeutics 1.91 Bn 423.03 Mn - -0.76
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.76
Mar 31, 2026 -0.45
Dec 31, 2025 -0.80
Sep 30, 2025 -0.66
Jun 30, 2025 -0.77
Mar 31, 2025 -1.15
Dec 31, 2024 -2.06
Sep 30, 2024 -10.25
Jun 30, 2024 3.22
Mar 31, 2024 -13.91
API Access

Maze Therapeutics EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=MAZE&period=max&api_key=YOUR_API_KEY